NANOSTRING TECHNOLOGIES, INC. 4,500,000 Shares of Common Stock Underwriting AgreementNanoString Technologies Inc • March 20th, 2019 • Biological products, (no disgnostic substances) • New York
NanoString Technologies, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom J.P. Morgan Securities LLC, UBS Securities LLC and Cowen and Company, LLC are acting as representatives (the “Representatives”), an aggregate of 2,500,000 shares of common stock, par value $0.0001 per share, of the Company, and Clarus Lifesciences II, L.P. (the “Selling Stockholder”) proposes to sell to the several Underwriters an aggregate of 2,000,000 shares of common stock of the Company (collectively, the “Underwritten Shares”). In addition, the Company proposes to issue and sell, at the option of the Underwriters, up to an additional 675,000 shares of common stock, par value $0.0001 per share, of the Company (the “Option Shares”). The Underwritten Shares and the Option Shares are herein referred to as the “Shares”. The shares of common stock of the Company to be outstanding after giving effect to th
